[Personalized therapy in non-small cell lung cancer: from diagnosis to therapy]

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Molecular targeted treatment is increasingly important for lung cancer patients.
• Molecular mapping of tumor tissue is essential for effective treatment selection.
• Cytotoxic chemotherapy lacks patient selection via biomarkers, but personalized approaches are emerging.

Purpose of the Study:

• To highlight the significance of molecular targeted therapy in lung cancer.
• To discuss the role of molecular mapping in personalized treatment strategies.
• To explore the evolving landscape of onco-pulmonology and its future directions.

Main Methods:

• Review of current literature on molecular targeted therapy in lung cancer.
• Analysis of the role of tumor tissue molecular profiling.
• Discussion of emerging therapeutic targets and personalized chemotherapy.

Main Results:

• Molecular targeted therapy offers significant hope, particularly for adenocarcinoma patients.
• Personalized chemotherapy may become viable for patients with specific comorbidities or uncertain applicability of traditional chemotherapy.
• Intensive research is continuously identifying promising new therapeutic targets.

Conclusions:

• Molecular targeted treatment and comprehensive tumor mapping are vital for advancing lung cancer care.
• The field of onco-pulmonology is rapidly evolving, providing hope through innovative therapeutic strategies.
• Personalized medicine approaches hold great promise for improving outcomes in lung cancer management.